At-Home Sexually Transmitted Infection (STI) Testing Market Size Growth: From $2.17 Billion In 2026 To $3.55 Billion By 2030
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
At-Home Sexually Transmitted Infection (STI) Testing Market Size Forecast: How Big Could The Market Get By 2030?
The at-home sexually transmitted infection (STI) testing market size has experienced rapid expansion in recent years. This market is projected to expand from $1.93 billion in 2025 to reach $2.17 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to this historical growth include the escalating global prevalence of sexually transmitted infections, greater recognition of the importance of early STI diagnosis and treatment, increased adoption of online healthcare and telemedicine services, broadening public health programs for HIV and STI screening, and a rising consumer preference for discreet home healthcare solutions.
The at-home sexually transmitted infection (STI) testing market size is anticipated to experience substantial growth in the upcoming years. It is projected to reach $3.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast period can be attributed to the increasing adoption of AI-enabled digital sexual health platforms, a rising demand for multiplex and rapid at-home STI diagnostic kits, the growing integration of connected and app-based testing ecosystems, the expanding availability of D2C healthcare distribution channels, and an increased focus on preventive sexual wellness and routine screening practices. Significant trends expected in this period include the rising adoption of discreet self-collection STI screening kits for private home-based testing, an increasing demand for rapid turnaround sexually transmitted infection diagnostic solutions, a growing preference among young adults for mail-in laboratory sexual health testing services, the expanding availability of multi-infection at-home sexual wellness testing panels, and the increasing expansion of online pharmacy and direct-to-consumer sexual health testing distribution channels.
Get A Free Sample Report With In-Depth Market Insights:
At-Home Sexually Transmitted Infection (STI) Testing Market Demand Drivers: What’s Powering Industry Growth?
The expanding understanding of sexual health is anticipated to propel the growth of the at-home sexually transmitted infection (STI) testing market in the future. This awareness refers to individuals’ comprehension of STIs, their transmission routes, prevention methods, and the vital role of consistent testing for early detection and treatment. The intensified focus on sexual health awareness is largely driven by public health campaigns and the destigmatization of STI testing, which encourages more individuals to proactively seek information and testing options. This rising awareness of sexual health boosts demand for at-home STI testing as it motivates individuals to seek confidential, convenient, and accessible testing solutions outside of traditional clinical settings. For instance, in December 2025, according to the UK Health Security Agency, a UK-based government agency, infectious syphilis diagnoses rose by 1.7%, increasing from 9,375 cases in 2023 to 9,535 cases in 2024. Therefore, growing awareness of sexual health is driving the growth of the at-home sexually transmitted infection (STI) testing market.
At-Home Sexually Transmitted Infection (STI) Testing Market Segment Analysis: What Are The Core Market Categories?
The at-home sexually transmitted infection (sti) testing market covered in this report is segmented –
1) By Type: Rapid Lateral Flow Immunoassays, Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits, Multiplex Panel Testing, Other Types
2) By Infection: Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Syphilis, Trichomoniasis, Human Papillomavirus (HPV), Hepatitis B And C, Other Infections
3) By Sample: Blood Samples, Urine Samples, Swab Samples
4) By Distribution: Online Pharmacies And D2C Platforms, Retail Pharmacies, Public Health Distribution Programs, Other Distributions
5) By End User: Individual Consumers, Healthcare Providers, Public Health Programs
Subsegments:
1) By Rapid Lateral Flow Immunoassays: Of Human Immunodeficiency Virus Antibody Detection, Of Syphilis Antibody Detection, Of Chlamydia Antigen Detection, Of Gonorrhea Antigen Detection, Of Hepatitis B Surface Antigen Detection
2) By Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits: Of Human Immunodeficiency Virus Nucleic Acid Detection, Of Chlamydia Trachomatis Nucleic Acid Detection, Of Neisseria Gonorrhoeae Nucleic Acid Detection, Of Trichomonas Vaginalis Nucleic Acid Detection, Of Mycoplasma Genitalium Nucleic Acid Detection
3) By Multiplex Panel Testing: Of Combined Human Immunodeficiency Virus And Syphilis Detection, Of Combined Chlamydia And Gonorrhea Detection, Of Comprehensive Bacterial Sexually Transmitted Infection Panel, Of Comprehensive Viral Sexually Transmitted Infection Panel, Of Multi Pathogen Sexual Health Screening Panel
4) By Other Types: Self-Collection Sample Kits, Mail-In Laboratory Testing Kits, Digital Or Connected At-Home Testing Kits, Microfluidic Lab-On-Chip Testing Kits
At-Home Sexually Transmitted Infection (STI) Testing Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies operating in the at-home STI testing market are concentrating on developing advanced diagnostic technologies, such as instrument-free polymerase chain reaction platforms. This effort is aimed at improving detection accuracy, shortening turnaround times, and expanding the availability of laboratory-quality results from home. Instrument-free polymerase chain reaction platforms are described as self-contained molecular diagnostic devices that enable users to collect samples at home and receive highly accurate pathogen detection results without needing traditional laboratory equipment, while also integrating digital systems for secure delivery of results and telehealth support. For instance, in November 2025, Visby Medical, a US-based medical diagnostics company, launched its FDA-authorized at-home PCR test for sexually transmitted infections. This test identifies chlamydia, gonorrhea, and trichomoniasis, delivers results in approximately 30 minutes, functions as an instrument-free single-use device, and integrates with digital platforms to provide secure result reporting and virtual care follow-up. It is designed to facilitate direct-to-consumer access, enhance molecular accuracy, improve testing convenience, and enable streamlined telehealth-supported treatment guidance.
At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the at-home sexually transmitted infection (sti) testing market are Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings, Randox Laboratories Ltd, LetsGetChecked, Everly Health Inc, myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest. co. uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd
View The Full At-Home Sexually Transmitted Infection (STI) Testing Market Report:
At-Home Sexually Transmitted Infection (STI) Testing Market Geographic Spread And Regional Opportunities
North America was the largest region in the at-home sexually transmitted infection (STI) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home sexually transmitted infection (STI) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
